1World

Revolutionizing Tourism with Web3: A Landmark Partnership Between Camino Network, DCM Swiss, 1World Online, and Web3-Solutions

Retrieved on: 
Tuesday, October 17, 2023
1World, Online, Web3, Partnership, Advertising, AI, Tourism, Partner, Travel, Entrepreneurship, Ecosystem, Marketing, Blockchain, DCM, Creative industries, Web 2.0, Lead validation

We are happy to announce that:

Key Points: 
  • We are happy to announce that:
    - DCM Swiss and 1World Online are becoming Validators at Camino Network.
  • - Web3-Solutions becomes a Regional Partner of DCM: A regional partnership agreement has been signed between DCM Swiss and Web3-Solutions to start the rollout of Web3 Tours services across Austrian cities.
  • "Adding two stellar companies like DCM and 1World to our network is a thrilling development for us.
  • The unique integration of blockchain, AI, and Web3 technologies ushers in a new, transformative era for the travel and tourism industry.

DCM Day: Web3 and The Future of Media

Retrieved on: 
Friday, March 17, 2023
1World, Online, NFT, Birla Institute of Technology and Science, Pilani, GE, Fédération des Entreprises Romandes Genève, Non-fungible token, Federation, Eventbrite, DCM, Festival, Digital, Creative industries

DCM DAY will focus on the exciting topic of Web3 and the Future of Media, exploring the latest developments and innovations in this rapidly-evolving field.

Key Points: 
  • DCM DAY will focus on the exciting topic of Web3 and the Future of Media, exploring the latest developments and innovations in this rapidly-evolving field.
  • DCM DAY promises to be a must-attend event for anyone interested in the future of media, including media professionals, entrepreneurs, technologists, investors, and anyone curious about the impact of Web3 on the media industry.
  • The panel discussion will cover a range of topics related to Web3 and the Future of Media, including the potential of blockchain technology for media distribution, the impact of NFTs on the media industry, and the role of decentralized finance in funding media projects.
  • The panelists will also explore the challenges and opportunities facing the media industry in the age of Web3, and share their predictions for the future of media.

Anew and OHA-Led Investor Consortium Acquire 1.7 Million Acre Timberland Portfolio to Expand Improved Forestry Management for Climate Action

Retrieved on: 
Wednesday, November 2, 2022
1World, Goal, Forest, Element Markets, Disaster, Climate change, Acquisition, River, FSC, Organization, GLOBE, TFG, LLC, Industry, T. Rowe Price, Disease, Certification, Ownership, Plant, World Resources Institute, Recreation, Tree, Sale, EV, TPG, United, Kirkland & Ellis, History, Carbon, Biodiversity, BSFC, Natural gas, Quality of life, Climate, Partnership, Solution, Forestry, OHA, Agriculture, Renewable energy

HOUSTON, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Anew Climate, LLC ("Anew") announced today the acquisition of entities managed by The Forestland Group ("TFG"), which includes a 1.7-million-acre timberland portfolio.

Key Points: 
  • HOUSTON, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Anew Climate, LLC ("Anew") announced today the acquisition of entities managed by The Forestland Group ("TFG"), which includes a 1.7-million-acre timberland portfolio.
  • BSFC has also entered into definitive agreements to acquire additional TFG-managed entities holding an additional 200,000 timberland acres.
  • "Forests, sustainably managed, are and will be a major climate mitigation tool with substantial benefits to local ecosystems and communities," stated Bill Townsend, Chief Strategy Officer, Anew.
  • Anew Climate, LLC ("Anew") is accelerating the fight against climate change by enabling companies and organizations to align their goals for conservation and impact with actionable next steps.

International Infection Prevention Week Serves to Highlight New Reprocessing Standards and Available Resources for Infection Preventionists

Retrieved on: 
Tuesday, October 18, 2022
1World, Olympus Corporation, Quality of life, Bureau of Oceans and International Environmental and Scientific Affairs, Perioperative, Risk, Transport, Association of periOperative Registered Nurses, Infection, Device file, Education, Association for Professionals in Infection Control and Epidemiology, Patient, Control, MBA, AAMI, Endoscopy, Multimedia, Senior, Automation, WHO, Hand, World Health Organization, World, Doctor of Philosophy, Association for the Advancement of Medical Instrumentation, Association, IFU, Health, Disinfectant, AORN, Safety, Medicine, APIC, Subclinical infection, Medical device, MD

CENTER VALLEY, Pa., Oct. 18, 2022 /PRNewswire/ -- Olympus Corp. of the Americas reminds infection prevention professionals of the importance of elevating the standard of patient care and safety during International Infection Prevention Week, which marks the Association for Professionals in Infection Control and Epidemiology's (APIC) 50th anniversary.

Key Points: 
  • Olympus partners with APIC and other professional organizations in providing education to infection prevention professionals and helping support reprocessing standards.
  • Olympus infection prevention tools and resources align with these standards, and our suite of cleaning, disinfection and sterilization products equip infection prevention professionals to comply with recommended guidelines.
  • With infection prevention as an issue at the fore this year, the World Health Organization promoted infection prevention measures with publication earlier this year of its "Global Report on Infection Prevention and Control."
  • 1World Health Organization, "Global Report on Infection Prevention and Control, executive summary," May 2022
    View original content to download multimedia: https://www.prnewswire.com/news-releases/international-infection-prevent...

Camille Schrier, Miss America 2020, and Castle Biosciences Partner to Expand Awareness of Genetic Testing in Depression and Anxiety

Retrieved on: 
Friday, May 6, 2022
Mental Health, Health, Genetics, General Health, Pharmaceutical, Biotechnology, 1World, Gene, Hope, COVID-19, Bipolar disorder, Genetic testing, Standard of care, Medicare, Personality disorder, Instagram, Twitter, Nasdaq, Anxiety, Health, Post-traumatic stress disorder, List of life sciences, DecisionDx-UM, Company, Panic disorder, Securities Exchange Act of 1934, Securities Act of 1933, Castle, Physician, Depression, Schizophrenia, Patient, Atopic dermatitis, Partnership, Mental Health Awareness Month, Virginia Commonwealth University, Annual report, Drug Quality and Security Act, Randomized controlled trial, Pharmacy, Precision medicine, LinkedIn, Attention deficit hyperactivity disorder, Uveal melanoma, Schrier, Education, View, Lists of diseases, Chronic pain, SEC, Mental health, Life, Awareness, Clifford Whittingham Beers, Multimedia, Miss America 2020, Pharmaceutical industry, Medicine, Facebook

The Company recently added IDgenetix, a pharmacogenomic (PGx) test for mental health conditions, to its portfolio of commercial tests.

Key Points: 
  • The Company recently added IDgenetix, a pharmacogenomic (PGx) test for mental health conditions, to its portfolio of commercial tests.
  • Started by the Mental Health America organization in 1949, Mental Health Awareness Month is designed to help increase awareness of the importance of mental health and wellness in the U.S.
  • This campaign seeks to help patients suffering from depression, anxiety and other mental health conditions to improve their chances of a beneficial medication response, Schrier continued.
  • DecisionDx-Melanoma, DecisionDx-CMSeq, DecisionDx-SCC, myPath Melanoma, DecisionDx DiffDx-Melanoma, DecisionDx-UM, DecisionDx-PRAME, DecisionDx-UMSeq, TissueCypher and IDgenetix are trademarks of Castle Biosciences, Inc.

Tonix Pharmaceuticals Announces Extension of Sponsored Research Agreement with Kansas State University to Develop Live-Virus Vaccine Against COVID-19

Retrieved on: 
Tuesday, April 5, 2022
1World, Autoimmunity, Company, Private Securities Litigation Reform Act, Virus, Psychiatry, Diagnosis, Long COVID, Therapy, Degenerative disease, Kansas State University, Risk, Monkeypox, Prader–Willi syndrome, Coronavirus, Fibromyalgia, Central nervous system, Vaccine, CNS, Research, SEC, Tablet, Hydrogen chloride, Disease, Cancer, Severe acute respiratory syndrome coronavirus 2, Immunity, U.S. Securities and Exchange Commission, Omicron, Pain, RPV, SL, Government, Security (finance), Neurology, Immune system, Technology, Infection, Cocaine, Nasdaq, Gene, GLOBE, World Health Organization, Department, Annual report, FDA, Smallpox, Immunization, Pharmaceutical industry, CD154, Tonix Pharmaceuticals, COVID-19

CHATHAM, N.J., April 05, 2022 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced a new preclinical research agreement with Kansas State University (K-State) to extend the research being performed under its original agreement. Tonix and K-State are working together to develop a vaccine candidate for the prevention of COVID-19 that utilizes a novel live virus vaccine vector platform, bovine parainfluenza virus, and also to test the effect of co-expression of the CD40-ligand, also known as CD154 or 5c8 antigen, to stimulate T cell immunity.

Key Points: 
  • Dr. Lederman continued, Modern live virus vaccines in development for COVID-19 use a vector system to present SARS-CoV-2 protein antigens.
  • A traditional live virus vaccine approach would use a weakened version of SARS-CoV-2, but SARS-CoV-2 contains genes that weaken the immune response by thwarting innate immunity.
  • Attenuated bovine parainfluenza virus has previously been shown to be an effective antigen delivery vector in humans2-7.
  • The research is being directed by Dr. Waithaka Mwangi, Kansas State University, Department of Diagnostic Medicine/Pathobiology, who is the inventor of the new technology.

Formula 1® Crypto.com Miami Grand Prix Announces Hard Rock® as First Founding Partner

Retrieved on: 
Wednesday, February 16, 2022
Crypto.com, 1World, NASDAQ, Formula One, F1, Formula One Group, Collection, STEM, Woman, Seminole, The Wall Street Journal, Hard Rock Stadium, Hard Rock Cafe, The Relix Bay Rock Shop, No. 1, Entertainment, Television, Forbes Magazine's List of America's Best Colleges, Grand Prix, Liberty Media, Formula, Forbes, HRI, J.D. Power, Multimedia, NFL, FIA, Hard Rock Stadium Circuit, Travel, Diversity, Nightclub, School

Scheduled to make its debut on 6-8 May, 2022, the Formula 1 Crypto.com Miami Grand Prix is the sport's newest race on the Formula 1 calendar.

Key Points: 
  • Scheduled to make its debut on 6-8 May, 2022, the Formula 1 Crypto.com Miami Grand Prix is the sport's newest race on the Formula 1 calendar.
  • The race will also provide an additional tourist boost and economic impact to local businesses in the greater Miami region.
  • HRI also launched a joint venture named Hard Rock Digital in 2020, an online sportsbook, retail sportsbook and internet gaming platform.
  • The FIA Formula 1World ChampionshipTM was inaugurated in 1950, unifying the sport of Grand Prix motor racing as the world's most prestigious motorsport competition.

EQRx Announces Partnership Agreement with Abdul Latif Jameel Health to Commercialize Lead Oncology Programs in Middle East, Turkey and Africa

Retrieved on: 
Monday, November 22, 2021
Oncology, Health, General Health, Research, Science, Pharmaceutical, Biotechnology, 1World, International Agency for Research on Cancer, NSCLC, Lung cancer, Esophageal cancer, TKI, Form, NMPA, APOLLO, New Drug Application, Prospectus, Risk, National Medical Products Administration, LinkedIn, Jameel, PD-L1, Organic, SEC filing, Social media, Catalog, Stomach, Failure, Method, Research, Sale, PIPE, Forward-looking statement, Large-cell lung carcinoma, Xi, Immunoglobulin G, Progression-free survival, Twitter, FDA, Ix, Growth, Securities Act of 1933, Patient, Adoption, Technology, Toxic Substances Control Act of 1976, Madison Avenue, EGFR, SEC, Proxy, Communication, Instagram, Antibody, III, Name, Disease, Pharmaceutical industry, Book, Lung Cancer, Aumolertinib, Sugemalimab, EQRx, LUNG CANCER, AUMOLERTINIB, SUGEMALIMAB, EQRX

Through the agreement, Abdul Latif Jameel Health will become EQRxs regulatory and commercial partner for aumolertinib and sugemalimab, if approved, in selected markets throughout the Middle East region, as well as in Turkey and all of Africa.

Key Points: 
  • Through the agreement, Abdul Latif Jameel Health will become EQRxs regulatory and commercial partner for aumolertinib and sugemalimab, if approved, in selected markets throughout the Middle East region, as well as in Turkey and all of Africa.
  • Its our joint mission with EQRx to change that, a mission that is aligned with the values of the Jameel Family.
  • Aumolertinib is a novel, irreversible EGFR-TKI that selectively inhibits both EGFR sensitizing and resistance mutations with high selectivity over wild-type EGFR.
  • EQRx and Remaking Medicine are trademarks of EQRx, Inc.
    1World Health Organization, International Agency for Research on Cancer.

Janssen Announces New World Hepatitis Alliance Report Calling for Change in the Fight Against Stigma and Discrimination Faced by More Than 90 Percent of People Living with Hepatitis B

Retrieved on: 
Monday, November 15, 2021
People, 1World, Johnson & Johnson, Metabolism, Behavior, Education, Depression, Security (finance), Cirrhosis, Hepatitis B, Policy, Janssen Pharmaceuticals, Doctor of Philosophy, Confidentiality, Diagnosis, WHA, Risk, SAN, Hepatitis, Infection, CDC, Medication, Research, Hepatitis B virus, Mental health, Trinidad and Tobago Securities and Exchange Commission, Research and development, Patient, Quality of life, Industry, Private Securities Litigation Reform Act, Medicine, Heart, Disease, World, World Hepatitis Alliance, Discrimination, World Health Organization, Liver, Liver cancer, Face, Centers for Disease Control and Prevention, LLC, Conditional sentence, Budget, Suicide, Employment, Viral hepatitis, Science, Anxiety, Fear, Impact, HIV, Self-harm, Vaccine, Mental, Annual report, Pulmonary hypertension, Janssen, Pharmaceutical industry

The report calls for urgent policy reform to address the ongoing stigma and discrimination faced by the global hepatitis B community.

Key Points: 
  • The report calls for urgent policy reform to address the ongoing stigma and discrimination faced by the global hepatitis B community.
  • "Systemic discrimination continues to threaten the livelihood of people living with hepatitis B around the world," said Cary James, Chief Executive Officer, World Hepatitis Alliance.
  • It's imperative that communities, civil society and policymakers take action now to discourage and end stigma and discrimination against those living with hepatitis B."
  • A hepatitis B cure is something everyone living with hepatitis B longs for; it would also be a cure for the social illness of hepatitis B stigma."

Oracle Promotes Responsible Use of AI in Financial Institutions

Retrieved on: 
Monday, October 4, 2021
Cloud, 1World, Economic Forum, World Economic Forum, Efficiency, Solution, Oracle Financial Services Software, Multimedia, MySQL, PricewaterhouseCoopers, Data management, Oracle Corporation, Decision-making, Cambridge Centre for Alternative Finance, Bias, Risk, Alternative, Uncertainty, Fraud, Technology, Intelligence, Java, Machine learning, NYSE, Medical device, Cryptocurrency, Online shopping, Software

Oracle Financial Services Compliance Studio is an advanced analytics application for financial institutions that supercharges anti-money laundering and anti-financial crime programs for more effective, efficient customer due diligence, transaction monitoring, and investigations.

Key Points: 
  • Oracle Financial Services Compliance Studio is an advanced analytics application for financial institutions that supercharges anti-money laundering and anti-financial crime programs for more effective, efficient customer due diligence, transaction monitoring, and investigations.
  • As part of the broader Oracle Financial Crime and Compliance Management suite, it offers built in AI, machine learning, graph analytics, and data management capabilities.
  • "There is clear consensus across financial institutions that AI and machine learning have tremendous potential to increase the effectiveness of anti-money laundering and other financial crime detection programs, and deliver higher efficiencies in the investigative process," said John Edison, group vice president, software development, Oracle Financial Services.
  • The new capabilities in Oracle Financial Services Compliance Studio provide the right governance and controls required to meet these objectives."